Home › Funds › PFM Health Sciences, LP › AXSM
PFM Health Sciences, LP position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
PFM Health Sciences, LP reported holding 222,102 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$41.0M, representing 4.19% of its reported portfolio and ranking #2 among its reported holdings. PFM Health Sciences, LP has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's AXSM position evolved
PFM Health Sciences, LP first disclosed a stake in AXSM in Q3 2023 at 523,210 shares (US$36.6M). The position peaked in Q1 2025 at 556,545 shares, worth US$64.9M. Across 13 filings, PFM Health Sciences, LP increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 222,102 shares valued at US$41.0M — an increase of 2,506 shares quarter over quarter.. Notable position changes include a 53% trim in Q4 2025 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 523.21K | $36.57M | New |
| Q4 2023 | 467.43K | $37.20M | Reduce |
| Q1 2024 | 467.43K | $37.30M | Hold |
| Q2 2024 | 467.43K | $37.63M | Hold |
| Q3 2024 | 467.43K | $42.01M | Hold |
| Q4 2024 | 467.43K | $39.55M | Hold |
| Q1 2025 | 556.54K | $64.91M | Add |
| Q2 2025 | 483.11K | $50.43M | Reduce |
| Q3 2025 | 530.33K | $64.41M | Add |
| Q4 2025 | 251.56K | $45.95M | Reduce |
| Q1 2026 | 264.30K | $44.67M | Add |
| Q2 2026 | 219.60K | $53.75M | Reduce |
| Q3 2026 | 222.10K | $40.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 43 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$147.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Sofinnova Investments, Inc. (US$82.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 800.00K sh · $147.51M · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K sh · $119.69M · Q3 2026
- Sofinnova Investments, Inc. 445.91K sh · $82.22M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 300.10K sh · $55.34M · Q3 2026
- SAMLYN CAPITAL, LLC 289.25K sh · $53.33M · Q3 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held AXSM?
PFM Health Sciences, LP has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in AXSM?
As of Q3 2026, PFM Health Sciences, LP holds 222.10K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $40.95M, representing 4.19% of its reported portfolio and ranking #2.
Has PFM Health Sciences, LP been buying or selling AXSM?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP increased its position in AXSM. The position peaked in Q1 2025 at 556.54K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Sofinnova Investments, Inc., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.